The cash price for popular weight-loss medication Wegovy is dropping by 30% in U.S. on Monday, according to Novo Nordisk.
Novo revealed Monday that the self-pay cost for the two lowest dosages of Wegovy and Ozempic will be $349 per month, down ...
1don MSN
Ozempic Costs Slashed
The drugs have become popular for their significant weight-loss effects, but their high cost has made them inaccessible for ...
Trump announced popular weight loss treatments would be offered directly on a new “TrumpRx.gov” website at lower prices.
Novo Nordisk A/S is undercutting arch-rival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback